Does the addition of vinorelbine to hormone therapy prolong survival of men with hormone-refractory prostate cancer?

2005 ◽  
Vol 2 (2) ◽  
pp. 80-81
Author(s):  
Karl Pummer
Keyword(s):  
Prostate Cancer ◽  
Hormone Therapy ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

The Prostate ◽  
2006 ◽  
Vol 66 (14) ◽  
pp. 1498-1511 ◽  
Author(s):  
Rajasubramaniam Shanmugam ◽  
Vetrichelvan Jayaprakasan ◽  
Yesim Gokmen-Polar ◽  
Stephanie Kelich ◽  
Kathy D. Miller ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Hormone Therapy ◽  
Hormone Refractory Prostate Cancer ◽  
Cancer Model ◽  
Hormone Refractory ◽  
Prostate Cancer Model

scholarly journals Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer

2004 ◽  
Vol 15 (11) ◽  
pp. 1613-1621 ◽  
Author(s):  
R.P. Abratt ◽  
D. Brune ◽  
M.-A. Dimopoulos ◽  
J. Kliment ◽  
J. Breza ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Hormone Therapy ◽  
Phase Iii ◽  
Hormone Refractory Prostate Cancer ◽  
Phase Iii Study ◽  
Hormone Refractory

Phase II study of oral vinorelbine plus hormone therapy in hormone-refractory prostate cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16075-16075
Author(s):  
F. Chiti ◽  
F. M. Calais da Silva ◽  
A. Canelas ◽  
P. Gonçalves ◽  
J. M. Gomes
Keyword(s):  
Prostate Cancer ◽  
Hormone Therapy ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Oral Vinorelbine ◽  
Hormone Refractory

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 202-202
Author(s):  
Hirotsugu Uemura ◽  
Motoyoshi Tanaka ◽  
Shigeya Uejima ◽  
Takafumi Minami ◽  
Kiyohide Fujimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

2005 ◽  
Vol 173 (4S) ◽  
pp. 225-225
Author(s):  
Peter Olbert ◽  
Andres J. Schrader ◽  
Axel Hegele ◽  
Zoltan Varga ◽  
Axel Heidenreich ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Impact ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document